1. Resistance to dopamine agonists in the treatment of prolactinomas: diagnostic criteria, mechanisms and ways to overcome it
   Irena A. Ilovayskaya et al, 2024, Almanac of Clinical Medicine CrossRef
2. Identifying prognostic predictors for postoperative pituitary neuroendocrine tumour recurrence: an integrated clinical, radiological, and immunohistochemistry assessment
   Chia-Yu Chen et al, 2024, British Journal of Neurosurgery CrossRef
3. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
   Eduardo J. Medina et al, 2023, Frontiers in Endocrinology CrossRef
4. Giant prolactinomas, a detailed analysis of 196 adult cases
   Billion Lisa et al, 2023, Pituitary CrossRef
5. Individual approach in the treatment of prolactinoma in a patient with multiple endocrine neoplasia type 1 syndrome
   E. N. Kravchuk et al, 2022, Russian Journal for Personalized Medicine CrossRef
6. Epilepsy associated with pituitary neuroendocrine tumors: Current status of problem and interdisciplinary approach
   A. V. Vasilenko et al, 2022, Medical alphabet CrossRef
7. Prolactinoma: Navigating the Dual Challenge of Side Effects and Treatment Strategies - A Comprehensive Review
   Fnu Yogeeta et al, 2024, Annals of Medicine & Surgery CrossRef
8. Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy
   Maria-Magdalena Georgescu et al, 2022, Cell Communication and Signaling CrossRef
9. Modern concepts of genetic and immunohistochemical features of prolactin-secreting pituitary adenomas
   A. S. Shutova et al, 2023, Problems of Endocrinology CrossRef